You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 4.2% | 4.3% |
Div Cover | 1.1 | 2.0 |
Op Mrgn | 18.3% | 24.0% |
ROCE | 37.5% |
Latest | Forecast | |
---|---|---|
P/E | 20.6 | 0.0 |
PEG | -0.6 | 0.2 |
Price / Revenue | 0.0 | 0.0 |
Price / Book value | 0.0 |
Latest | Forecast | |
---|---|---|
Revenue | 0.2% | 0.0% |
PBT | -31.4% | n/a |
EPS | -35.6% | 0.0% |
DPS | 5.6% | 0.0% |
Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 36,126.00 | 3,077.00 | €2.33 | 38.5 | -1.2 | -33% | €3.15 | 3.5% |
2020-12-31 | 36,041.00 | 13,778.00 | €0.10 | 802.2 | -8.4 | -96% | €3.20 | 4.1% |
2021-12-31 | 37,761.00 | 7,798.00 | €4.97 | 17.8 | 0.0 | 4,966% | €3.33 | 3.8% |
2022-12-31 | 42,997.00 | 10,422.00 | €6.69 | 13.4 | 0.4 | 35% | €3.56 | 4.0% |
2023-12-31 | 43,070.00 | 7,153.00 | €4.31 | 20.8 | -0.6 | -36% | €3.76 | 4.2% |
Sanofi shares tank on consumer spin-off plans, Q3 profit miss Sharecast News | 27 Oct |
---|---|
GSK settles California Zantac lawsuit Sharecast News | 11 Oct |
AstraZeneca, Sanofi infant respiratory treatment gets US approval Sharecast News | 18 Jul |